Forward Pharma A/S logo
Forward Pharma A/S FWP

Annual report 2021
added 12-23-2023

report update icon

Forward Pharma A/S Operating Expenses 2011-2026 | FWP

Annual Operating Expenses Forward Pharma A/S

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 3.39 M 5.28 M 12.3 M 37.6 M 55.4 M 49.6 M 19.7 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
55.4 M 3.39 M 26.2 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer Operating Expenses Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
432 M - 2.43 % $ 254 M germanyGermany
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
216 M $ 21.87 2.15 % $ 1.02 B usaUSA
I-Mab I-Mab
IMAB
1.49 B - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
210 M - - $ 1.01 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
4.78 M - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
2.66 B - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
20.7 M $ 0.9 - $ 6.62 M chinaChina
Genfit SA Genfit SA
GNFT
78.3 M - 2.54 % $ 160 B franceFrance
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
708 M $ 22.28 1.46 % $ 3.69 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
8.22 M - -1.52 % $ 24.7 M usaUSA
Advaxis Advaxis
ADXS
22 M - -9.65 % $ 45.9 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
179 M - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
86.8 M - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
196 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
46.2 M - 4.14 % $ 49.1 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
9.57 M - -11.43 % $ 502 K usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
629 M - - - russiaRussia
Applied Molecular Transport Applied Molecular Transport
AMTI
127 M - - $ 10.1 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
13.3 M - 5.93 % $ 314 M canadaCanada
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
31.7 M - -2.5 % $ 5.88 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
74.5 M - - $ 8.42 M usaUSA
Aptinyx Aptinyx
APTX
62.6 M - -39.0 % $ 4.57 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
24.2 M - -10.17 % $ 12.2 K usaUSA
Aravive Aravive
ARAV
80 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
23.4 K - 17.91 % $ 11.1 M usaUSA
BioNTech SE BioNTech SE
BNTX
512 M $ 105.26 -0.19 % $ 27.2 B germanyGermany
Avenue Therapeutics Avenue Therapeutics
ATXI
4.49 M - -52.27 % $ 4.45 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
66.5 M - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
85.5 M $ 4.1 0.37 % $ 438 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
137 M $ 23.98 3.07 % $ 3.05 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
29.8 M - - $ 7.46 M israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
145 M $ 1.47 1.74 % $ 391 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
24.7 M - -45.71 % $ 1.2 M canadaCanada
AstraZeneca PLC AstraZeneca PLC
AZN
17.6 B - - $ 96.9 B britainBritain
AVROBIO AVROBIO
AVRO
71.7 M - 1083.1 % $ 745 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
14 M $ 2.98 2.41 % $ 4.91 M israelIsrael
BioDelivery Sciences International BioDelivery Sciences International
BDSI
106 M - -4.8 % $ 255 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
390 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Akero Therapeutics Akero Therapeutics
AKRO
80.2 M - - $ 3.67 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
88.9 M - - $ 867 M germanyGermany
bluebird bio bluebird bio
BLUE
854 M - - $ 546 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
64.6 M - -5.16 % $ 5.39 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
49.6 M $ 1.72 - $ 115 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
107 M $ 1.1 3.76 % $ 13.4 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
172 M $ 2.97 0.68 % $ 298 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
26.7 M - -3.03 % $ 260 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
47.6 M - 3.16 % $ 1.9 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
38.9 M - - $ 35.4 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
133 M - - $ 3.45 B usaUSA